Deep Dives, AI, Drug Development, Drug Discovery.
startups, investors, and medtech and pharma companies at the AI For Health Summit in Paris on November 16. Owkin will be among them. But with the high risks involved in creating feasible treatments, and the limited history of the technology platforms involved, investors, who have poured billions of